We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Sarah
Kingsbury
s.r.kingsbury@leeds.ac.uk
Prof
Philip
Conaghan
p.conaghan@leeds.ac.uk
ArthrosisOther soft tissue disordersNerve, nerve root and plexus disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
In this research programme we will develop and evaluate a digital rehabilitation programme (Digital-My Arm Pain Programme, D-MAPP) to support people with distal upper limb musculoskeletal disorders (including hand, wrist and thumb osteoarthritis (OA), carpal tunnel syndrome, tendinitis and epicondylitis (known as tennis elbow). D-MAPP will include an exercise programme tailored to the specific condition and the patients’ current level of function, together with education to help them look after their own condition (self-management).
The 6-year programme includes 4 workpackages (WPs):
WP1 will review published evidence and obtain agreement from experts and patients using a series of structured questionnaires (a Delphi study). This will establish the main building blocks for the D-MAPP intervention (e.g. exercise programme content, areas for self-management support). We will use focus groups to explore patients’ views on barriers and facilitators to using digital programmes.
WP2 - We will work closely with patients and healthcare professionals to co-design D-MAPP, using the building blocks identified in WP1. We will test how acceptable D-MAPP is to patients using interviews.
WP3 (We will seeking ethical approval for WP3 in a separate application)-
We will use a large clinical trial to formally test whether D-MAPP has the desired benefit on function and pain for people with these conditions, compared to usual clinical care. We will compare NHS costs between groups, to see whether the intervention is good value-for-money, and learn about participants’ experiences of using D-MAPP.
WP4 (‘Implementation’) will consider the practical steps needed to roll-out D-MAPP widely to everybody with these conditions through routine clinical practice. This will include communication, education and publicising D-MAPP.
This novel digital rehabilitation programme has potential to provide better pain control, improved physical function and, if relevant, enhanced work participation for many millions. The D-MAPP will also reduce burden on overstretched healthcare services.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
WP1i, WP1a, WP1b and WP4a A patient who has DUL pain due to any of the following conditions: fracture, referred pain (e.g. from the neck or shoulder), cancer, systemic inflammatory condition or inflammatory arthritis (e.g. rheumatoid arthritis), diabetic peripheral neuropathies or peripheral nerve injuries.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Leeds and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 51228
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
